The Promise and Challenge of Allogeneic Cell Therapies In the realm of cancer treatment, few innovations have generated as much excitement as cell therapies. The first wave of approved CAR-T therapies demonstrated remarkable efficacy against previously untreatable blood cancers, offering hope to patients who had exhausted conventional treatment options. However, these autologous (patient-derived) treatments came … Continue reading The Supply Chain Revolution Behind “Off-the-Shelf” Cell Therapies